Difficulty: Medium
Average Score: 90%
Practice
A nurse is caring for a client, PP2, who is preparing to go home with her infant. The nurse notes that the client's blood type is O├ó╦åÔÇÖ (negative), the baby's type is A+ (positive), and the direct Coombs' test is negative. Which of the following actions by the nurse is appropriate?
Correct answer
B
Rationale
The correct answer is B: Make sure that the client receives a RhoGAM injection before she is discharged from the hospital.
In the context of postpartum care, when a mother is Rh-negative and the baby is Rh-positive, there is a risk of Rh incompatibility. If fetal blood enters the maternal circulation during childbirth, the mother's immune system can mount an immune response against the Rh-positive blood cells, leading to potential issues in subsequent pregnancies.
RhoGAM is administered to Rh-negative mothers to prevent this immune response. It works by binding to any fetal Rh-positive cells in the mother's bloodstream, preventing her immune system from reacting to them. Administering RhoGAM within 72 hours postpartum is crucial to prevent sensitization in future pregnancies.
The other options are incorrect because:
A) Waiting until the end of the week for the RhoGAM injection is too late to be effective.
C) The baby's negative Coombs' test does not negate the need for the mother to receive RhoGAM.
D) Discharge timing should not delay the administration of RhoGAM, as it is time-sensitive.
Understanding the rationale behind the administration of RhoGAM in Rh-negative mothers is essential for nurses to provide safe and effective care to postpartum clients and their infants. It highlights the importance of timely interventions to prevent complications in future pregnancies due to Rh incompatibility.
In the context of postpartum care, when a mother is Rh-negative and the baby is Rh-positive, there is a risk of Rh incompatibility. If fetal blood enters the maternal circulation during childbirth, the mother's immune system can mount an immune response against the Rh-positive blood cells, leading to potential issues in subsequent pregnancies.
RhoGAM is administered to Rh-negative mothers to prevent this immune response. It works by binding to any fetal Rh-positive cells in the mother's bloodstream, preventing her immune system from reacting to them. Administering RhoGAM within 72 hours postpartum is crucial to prevent sensitization in future pregnancies.
The other options are incorrect because:
A) Waiting until the end of the week for the RhoGAM injection is too late to be effective.
C) The baby's negative Coombs' test does not negate the need for the mother to receive RhoGAM.
D) Discharge timing should not delay the administration of RhoGAM, as it is time-sensitive.
Understanding the rationale behind the administration of RhoGAM in Rh-negative mothers is essential for nurses to provide safe and effective care to postpartum clients and their infants. It highlights the importance of timely interventions to prevent complications in future pregnancies due to Rh incompatibility.